Skip to Content
Merck
  • ABR, a novel inducer of transcription factor C/EBPα, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemia.

ABR, a novel inducer of transcription factor C/EBPα, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemia.

Oncotarget (2017-12-22)
Carolina Yaeko Namasu, Christiane Katzerke, Daniela Bräuer-Hartmann, Alexander Arthur Wurm, Dennis Gerloff, Jens-Uwe Hartmann, Sebastian Schwind, Carsten Müller-Tidow, Nadja Hilger, Stephan Fricke, Maximilian Christopeit, Dietger Niederwieser, Gerhard Behre
ABSTRACT

Active

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® esiRNA, targeting human ABR